| Dr Carissa M Barina, MD | |
|
30 N Emerson Ave, Greenwood, IN 46143-8895 | |
| (317) 881-3937 | |
| (317) 887-4008 |
| Full Name | Dr Carissa M Barina |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 22 Years |
| Location | 30 N Emerson Ave, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245266600 | NPI | - | NPPES |
| 000000483017 | Other | IN | BCBS |
| 200840910 | Medicaid | IN | |
| P00371970 | Other | IN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01062315A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Eye Clinic, Llc | 8820094683 | 5 |
News Archive
Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae - a bacterium that causes deadly pneumonia, meningitis and sepsis - could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections with indwelling devices and surgical procedures such as hip replacements.
Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).
› Verified 8 days ago
| Entity Name | Midwest Eye Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912960535 PECOS PAC ID: 2961399217 Enrollment ID: O20040302000158 |
News Archive
Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae - a bacterium that causes deadly pneumonia, meningitis and sepsis - could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections with indwelling devices and surgical procedures such as hip replacements.
Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).
› Verified 8 days ago
| Entity Name | Indiana Eye Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013905827 PECOS PAC ID: 8820094683 Enrollment ID: O20061018000504 |
News Archive
Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae - a bacterium that causes deadly pneumonia, meningitis and sepsis - could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections with indwelling devices and surgical procedures such as hip replacements.
Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carissa M Barina, MD 30 N Emerson Ave, Greenwood, IN 46143-8895 Ph: (317) 881-3937 | Dr Carissa M Barina, MD 30 N Emerson Ave, Greenwood, IN 46143-8895 Ph: (317) 881-3937 |
News Archive
Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae - a bacterium that causes deadly pneumonia, meningitis and sepsis - could substantially reduce death and serious illness among children in the developing world. If used widely, a pneumococcal conjugate vaccine could prevent hundreds of thousands of child deaths each year.
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections with indwelling devices and surgical procedures such as hip replacements.
Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).
› Verified 8 days ago
Vibhuti Prian Jani, Ophthalmology Medicare: Medicare Enrolled Practice Location: 745 N Us Highway 31 N Ste D, Greenwood, IN 46142 Phone: 317-859-9397 | |
Dr. Christopher Bauer Pesavento, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 202, Greenwood, IN 46143 Phone: 317-215-2833 Fax: 317-215-2838 | |
Charles Owen Mccormick Iii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 30 N Emerson Ave, Greenwood, IN 46143 Phone: 317-881-3937 Fax: 317-887-4008 | |
William Forrest Keeling, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 30 N Emerson Ave, Greenwood, IN 46143 Phone: 317-881-3937 Fax: 317-887-4008 | |
Dr. Carissa Lynn Klaas I, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5645 Mockingbird Ln, Greenwood, IN 46143 Phone: 317-692-1249 | |
Nicholas Robert Rader, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 30 N Emerson Ave, Greenwood, IN 46143 Phone: 317-881-3937 Fax: 317-887-4008 |